Patient characteristics
| . | n (%) . |
|---|---|
| Median age, y (range) | 33 (4-62) |
| Age groups | |
| < 10 y | 7 (4.6) |
| 10-20 y | 16 (10.6) |
| 21-40 y | 86 (60.0) |
| > 40 y | 42 (27.8) |
| Male/female | 89 (59)/62 (41) |
| Donor:patient sex mismatch | |
| None | 76/150* (50.6) |
| Female to male | 44/150 (29.3) |
| Male to female | 30/150 (20.1) |
| Disease status | |
| Early (CR1 and chronic phase) | 93/151 (61.6) |
| Late (all others) | 58/151 (38.4) |
| Donor type | |
| HLA-identical, related | 140/151 (92.7) |
| HLA-identical, unrelated | 8/151 (5.2) |
| One antigen mismatch | 3/151 (2.1) |
| Transplant time frame | |
| 1979-1989 | 80/151 (53.0) |
| 1990-1998 | 71/151 (47.0) |
| GVHD prophylaxis | |
| Cyclosporine alone | 141/151 (93.4) |
| Others | 10/151 (6.6) |
| T-cell depletion | 33/151 (21.8) |
| Acute GVHD grade | |
| 0 | 31/151 (20.5) |
| 1 (cutaneous) | 65/151 (43.0) |
| 2-4 (systemic) | 55/151 (36.5) |
| Follow-up of survivors, median | |
| After diagnosis of cGVHD, y (range) | 7.8 (0.2-20.6) |
| . | n (%) . |
|---|---|
| Median age, y (range) | 33 (4-62) |
| Age groups | |
| < 10 y | 7 (4.6) |
| 10-20 y | 16 (10.6) |
| 21-40 y | 86 (60.0) |
| > 40 y | 42 (27.8) |
| Male/female | 89 (59)/62 (41) |
| Donor:patient sex mismatch | |
| None | 76/150* (50.6) |
| Female to male | 44/150 (29.3) |
| Male to female | 30/150 (20.1) |
| Disease status | |
| Early (CR1 and chronic phase) | 93/151 (61.6) |
| Late (all others) | 58/151 (38.4) |
| Donor type | |
| HLA-identical, related | 140/151 (92.7) |
| HLA-identical, unrelated | 8/151 (5.2) |
| One antigen mismatch | 3/151 (2.1) |
| Transplant time frame | |
| 1979-1989 | 80/151 (53.0) |
| 1990-1998 | 71/151 (47.0) |
| GVHD prophylaxis | |
| Cyclosporine alone | 141/151 (93.4) |
| Others | 10/151 (6.6) |
| T-cell depletion | 33/151 (21.8) |
| Acute GVHD grade | |
| 0 | 31/151 (20.5) |
| 1 (cutaneous) | 65/151 (43.0) |
| 2-4 (systemic) | 55/151 (36.5) |
| Follow-up of survivors, median | |
| After diagnosis of cGVHD, y (range) | 7.8 (0.2-20.6) |
GVHD indicates graft-versus-host disease; cGVHD, chronic graft-versus-host disease.
Denominator indicates number of patients for whom data was present.